Imago BioSciences Statistics Share Statistics Imago BioSciences has 0
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding n/a Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares 48,048 FTD / Avg. Volume 6.3%
Short Selling Information The latest short interest is 1.1M, so 0% of the outstanding
shares have been sold short.
Short Interest 1.1M Short % of Shares Out n/a Short % of Float 5.77% Short Ratio (days to cover) 2.8
Valuation Ratios The PE ratio is -18.82 and the forward
PE ratio is null.
Imago BioSciences's PEG ratio is
-0.32.
PE Ratio -18.82 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 3.71 P/FCF Ratio -20.03 PEG Ratio -0.32
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Imago BioSciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 21.93,
with a Debt / Equity ratio of 0.
Current Ratio 21.93 Quick Ratio 21.93 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -133.74
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.03M Employee Count 41 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 2K Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0, so Imago BioSciences's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average 29.83 200-Day Moving Average 19.59 Relative Strength Index (RSI) 86.31 Average Volume (20 Days) 762,778
Income Statement
Revenue n/a Gross Profit n/a Operating Income -41.99M Net Income -42.31M EBITDA -42.52M EBIT -41.99M Earnings Per Share (EPS) -1.26
Full Income Statement Balance Sheet The company has 11.23M in cash and 0 in
debt, giving a net cash position of 11.23M.
Cash & Cash Equivalents 11.23M Total Debt n/a Net Cash n/a Retained Earnings -112.65M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -39.76M
and capital expenditures 0, giving a free cash flow of -39.76M.
Operating Cash Flow -39.76M Capital Expenditures n/a Free Cash Flow -39.76M FCF Per Share -1.18
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
